Lv3
390 积分 2025-11-14 加入
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
4天前
已完结
Alternative splicing: a bridge connecting NAFLD and HCC
4天前
已完结
NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options
4天前
已完结
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
4天前
已完结
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
4天前
已完结
Global epidemiology of cirrhosis — aetiology, trends and predictions
5天前
已完结
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity
17天前
已完结
Liver organoid as a 3D in vitro model for drug validation and toxicity assessment
17天前
已完结
An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells
17天前
已完结
Spatiotemporal control of SMARCA5 by a MAPK–RUNX1 axis distinguishes mutant KRAS-driven pancreatic malignancy from tissue regeneration
22天前
已完结
皖公网安备34019202002308
